Molecular basis of vanadium-mediated inhibition of hepatocellular preneoplasia during experimental hepatocarcinogenesis in rats

Journal of Cellular Biochemistry

Volumn 101, Issue 1, 2007, Pages 244-258

  Chakraborty, Tridib ^a   Swamy, A H M Viswanatha ^a   Chatterjee, Amrita ^a   Rana, Basabi ^b   Shyamsundar, A ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

8 OHdGs; Cell proliferation; Chromosomal aberrations; DNA damage; DNA strand breaks; DNA protein crosslinks; Hepatocarcinogenesis; Metallothionein; Preneoplasia; Vanadium

Indexed keywords

8 HYDROXYGUANINE; DEOXYGUANOSINE DERIVATIVE; DIETHYLNITROSAMINE; METALLOTHIONEIN; SINGLE STRANDED DNA; VANADIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG MECHANISM; IMMUNOREACTIVITY; LIVER CARCINOGENESIS; LIVER TUMOR; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; DIETHYLNITROSAMINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PHENOBARBITAL; PRECANCEROUS CONDITIONS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VANADIUM;

RATTUS;

EID: 34247521003     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21169     Document Type: Article

References (61)

1. Basak J. 1996. Estimation of single-strand breaks induced in the dried film of DNA by high energy alpha particle from a cyclotron. Ind J Biochem Biophys 33:35-38.
2. 3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis. Life Sci 68:217-231.
3. 3 inhibit diethylnitrosamine induced rat liver carcinogenesis. Chem Biol Interact 128:1-18.
4. Bishayee A, Chatterjee M. 1995. Time course effects of vanadium supplement on cytosolic reduced glutathione level and glutathione S-transferase activity. Biol Trace Elem Res 48:275-285.
5. Bishayee A, Roy S, Chatterjee M. 1999. Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis. Oncol Res 11:41-53.
6. Cattley RC, Glover SE. 1993. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to carcinogenesis and nuclear localization. Carcinogenesis 14:2495-2499.
7. Chakraborty T, Samanta S, Ghosh B, Thirumoorthy N, Chatterjee M. 2005. Vanadium induces apoptosis and modulates the expressions of metallothionein, Ki-67 nuclear antigen, and p53 during 2-acetylaminofluorene-induced rat liver preneoplasia. J Cell Biochem 94:744-762.
8. Dahlaus M, Appel KE. 1993. N-nitrosodimethylamine, N-nitrosodiethylamine, and N-nitrosomorpholine fail to generate 8-hydroxy-2′-deoxyguanosine in liver DNA of male F344 rats. Mutat Res 285:295-302.
9. D'Cruz OJ, Uckun FM. 2002. Metvan: A novel oxovanadium(IV) complex with broad spectrum anticancer activity. Expert Opin Invest Drugs 11:1829-1836.
10. De Flora S, Ferguson LR. 2005. Overview of mechanisms of cancer chemopreventive agents. Mutat Res 591:8-15.
11. de Moura Espindola R, Mazzantini RP, Ong TP, de Conti A, Heidor R, Moreno FS. 2005. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation. Carcinogenesis 26:1091-1099.
12. Dragon YP, Hully J, Crow R, Mass M, Pitot HC. 1994. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. Carcinogenesis 15:1939-1947.
13. Evangelou AM. 2002. Vanadium in cancer treatment. Crt Rev Oncol Hematol 42:249-265.
14. Farber E. 1984a. Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Res 44:5463-5474.
15. Farber E. 1984b. The multistep nature of cancer development. Cancer Res 44:4217-4223.
16. Farber E. 1990. Clonal adaptation during carcinogenesis. Biochem Pharmacol 39:1837-1846.
17. Farber E, Cameron R. 1980. The sequential analysis of cancer development. Adv Cancer Res 31:125-226.
18. Floyd RA. 1990. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11:1447-1450.
19. French RJ, Jones PJ. 1993. Role of vanadium in nutrition: Metabolism, essentiality and dietary consideration. Life Sci 52:339-346.
20. Grover S, Fisher P. 1971. Cytogenetic studies in Sprague-Dawley rats during the administration of carcinogen nitroso compound-diethynitrosamine. Eur J Cancer 7:77-82.
21. Gupta RC. 1984. Nonrandom binding of the carcinogen N-hydroxy-2- acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 81:6943-6947.
22. Hamilton EE, Wilker JJ. 2004a. Inorganic oxo compounds react with alkylating agents: Implications for DNA damage. Angew Chem Int Ed Eng 43:3290-3292.
23. Hamilton EE, Wilker JJ. 2004b. Inhibition of DNA alkylation damage with inorganic salts. J Biol Inorg Chem 9:894-902.
24. Hamilton EE, Fanwick PE, Wilker JJ. 2002. The elusive vanadate (V(3)O(9))(3-): Isolation, crystal structure, and nonaqueous solution behavior. J Am Chem Soc 124:78-82.
25. Hamilton EE, Fanwick PE, Wilker JJ. 2006. Alkylation of inorganic oxo compounds and insights on preventing DNA damage. J Am Chem Soc 128:3388-3395.
26. Hopkins LL, Jr., Mohr HE. 1971. The biological essentiality of vanadium. In: Mertz W, Cornatzer WE, editors. Newer trace elements in nutrition. New York: Marcel Dekker. pp 195-213.
27. Horiuchi T, Ito K, Suzuki M, Umeda M. 1984. Sensitive induction of chromosome aberration in the in-vivo liver cells of rats by N- nitrosodiethylamine. Mutat Res 140:181-185.
28. Huang GW, Yang LY. 2002. Metallothionein expression in hepatocellular carcinoma. World J Gastroenterol 8:650-653.
29. Jackson SP. 2002. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687-696.
30. Jayasurya A, Bay BH, Yap WM, Tan NG, Tan BKH. 2000. Proliferative potential in nasopharyngeal carcinoma: Correlations with metallothionein expression and tissue zinc levels. Carcinogenesis 21:1809-1812.
31. Jia G, Tohyama C, Sone H. 2002. DNA damage triggers imbalance of proliferation and apoptosis during development of preneoplastic foci in the liver of Long-Evans Cinnamon rats. Int J Oncol 21:755-761.
32. Jin R, Chow VTK, Tan PH, Tan PH, Dheen ST, Duan W, Bay BH. 2002. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23:81-86.
33. Kasai H. 1997. Analysis of a form of oxidative DNA damage, 8-hydroxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147-163.
34. Kasprzak KS, Waalkes MP. 1986. The role of calcium, magnesium, and zinc in carcinogenesis. Adv Exp Med Biol 206:497-515.
35. Kato T, Hasegawa R, Nakae D, Hirose M, Yamao M, Kobayashi Y, Konishi Y, Ito N, Shirai T. 1996. Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by food-derived carcinogen, 2-amino-3,8- dimethylimidazo[4,5-f]quinoline at low dose levels. Jpn J Cancer Res 87:127-133.
36. Kopf-Maier P, Kopf H. 1988. Transition and main-group metal cyclopentadienyl complexes: Preclinical studies on a series of antitumor agents of different structural type. Struct Bond 70:103-185.
37. Köpf-Maier P. 1994. Complexes of metals other than platinum as anti-tumour agents. Eur J Clin Pharmacol 47:1-16.
38. Land H, Parada LF, Weinberg RA. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771-778.
39. 3H-thymidine for studies of hepatocellular proliferation in rodents. Carcinogenesis 10:1341-1343.
40. Lindahl T. 1993. Instability and decay of the primary structure of DNA. Nature 362:709-715.
41. Moreno FS, Rizzi MBSL, Dagli MLZ, Penteado MVC. 1991. Inhibitory effect of β-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model. Carcinogenesis 12:1817-1822.
42. Nakae D, Kobayashi Y, Akai H, Andoh N, Satox H, Ohashi K, Tsutsumi M, Konishi Y. 1997. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 57:1281-1287.
43. Navara CS, Benyumov A, Vassilev A, Narla RK, Ghosh P, Uckun FM. 2001. Vanadocenes as potent anti-proliferative agents disrupting mitotic spindle formation in cancer cells. Anticancer Res 12:369-376.
44. Nielsen FH, Uthus EO. 1980. The essentiality and metabolism of vanadium. In: Chasteen ND, editor. Vanadium in biological systems. Dordrecht: Kluwer Academic Publishers. pp 51-62.
45. Oleinick NL, Chiu SM, Ramakrishnan N, Xue LY. 1987. The formation, identification, and significance of DNA-protein crosslinks in mammalian cells. Br J Cancer 55:135-140.
46. Oyama T, Take H, Hikino T, Lino Y, Nakajima T. 1996. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 53:112-117.
47. Park JW, Cundi KC, Ames BN. 1989. Detection of DNA adducts by high-performance liquid chromatography with electrochemical detection. Carcinogenesis 10:827-832.
48. Peraino C, Staffeldt EF, Ludeman VA. 1981. Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth. Carcinogenesis 2:463-465.
49. Sakurai H, Tamura H, Okatani K. 1995. Mechanism for a new antitumor vanadium complex: Hydroxyl radical dependent DNA cleavage by 1, 10-phenanthroline-vanadyl complex in the presence of hydrogen peroxide. Biochem Biophys Res Commun 206:133-137.
50. Sarkar A, Basak R, Basak J, Chatterjee M. 1997. Beta carotene prevents rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. Br J Cancer 76:855-861.
51. Schulte-Hermann R, Ohde G, Schuppler J, Timmermann-Trosiener I. 1981. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res 41:2556-2562.
52. Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J. 1982. Response of liver foci in rats to hepatic tumor promoters. Toxicol Pathol 10:63-70.
53. Scrivens PJ, Alaoui-Jamali MA, Giannini G, Wang T, Loignon M, Batist G, Sandor VA. 2003. Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues. Mol Cancer Ther 2:1053-1059.
54. Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A. 2001. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res 496:171-180.
55. Shen HM, Ong CN, Lee BL, Shi CY. 1995. Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 16:419-422.
56. Shen J, Wanibuchi H, Salim EI, Wei M, Kinoshita A, Yoshida K, Endo G, Fukushima S. 2003. Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats - association with oxidative DNA damage and enhanced cell proliferation. Carcinogenesis 24:1827-1835.
57. Stern A, Yin X, Tsang SS, Davidson A, Moon AJ. 1993. Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71:103-112.
58. Stewart HL, Williams GM, Keysser CH, Lombard LS, Montail RJ. 1980. Histological typing of liver tumors of the rat. J Natl Cancer Inst 64:117-207.
59. Sugiyama M, Wang XW, Costa M. 1986. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. Cancer Res 46:4547-4551.
60. Vu V, Moller ME, Grantham PH, Wirth PJ, Thorgeirsson SS. 1985. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2- acetylaminofluorene and N-acetoxy-2-acetylaminofluorene. Carcinogenesis 6:45-52.
61. Zhitkovich A, Costa MA. 1992. A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. Carcinogenesis 13:1485-1489.